Home Compare CFLT vs IONS
Stock Comparison · Single-driver result

Confluent vs Ionis Pharmaceuticals: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Confluent carrying a narrow edge on growth. Ionis Pharmaceuticals still leads on profitability and stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Growth still does most of the heavy lifting in this comparison.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #24
within Confluent, Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The match is driven mainly by investment intensity and revenue growth trajectory.

Similarity drivers
investment intensityrevenue growth trajectory
What reduces the match
margin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
CFLT
Confluent, Inc.
31
Peer-Score
Signal qualityHigh
vs
IONS
Ionis Pharmaceuticals, Inc.
27
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: CFLT vs IONS Profitability 7 17 Stability 25 48 Valuation 42 30 Growth 55 18 CFLT IONS
Gap Ranking
#1 Growth +37
#2 Stability +23
#3 Valuation +12
#4 Profitability +10
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for CFLT and IONS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer CFLTIONS Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Confluent, Inc..

Valuation position uses Forward P/E and peer-relative valuation score where available.

Relative Position vs Comparable Companies
Growth
On growth, Confluent, Inc. is positioned higher in the group, while Ionis Pharmaceuticals, Inc. is closer to the middle.
Stability
Ionis Pharmaceuticals, Inc. holds the stronger peer position on stability.
Growth — Dominant Gap
CFLT
55
IONS
18
Gap+37in favour of CFLT

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

Stability still leans toward Ionis Pharmaceuticals, Inc., so the lead is real without reading as one-way.

What this means for the comparison

Growth is the clearest driver of the lead, with stability adding further support — though profitability still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the CFLT vs IONS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how CFLT and IONS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.